CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology
Patients with normal‑range CA19‑9 levels represent a distinct subgroup of pancreatic cancer patients
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect
Southwest Journal of Pulmonary, Critical Care and Sleep - Pulmonary - Elevated Tumor Markers In Coccidioidomycosis of the Female Genital Tract
CA-19-9 - Diagnostic Kit
Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
PDF) Pancreatic Cancer with Normal CA 19-9 and Lewis Antigen Negative-Case Report | Journal of Pharmacy and Pharmacology - Academia.edu
extreme High levels of ca19-9 associated with adenocarcinoma of the lung
Patient selection criteria. GB, gallbladder; CA 19-9, carbohydrate... | Download Scientific Diagram
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice | Science
Clinical analysis of four serum tumor markers in 458 patients with ova | CMAR
Clinical analysis of four serum tumor markers in 458 patients with ova | CMAR
Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer - Yang - Journal of Gastrointestinal Oncology
Clinical Significance and Revisiting the Meaning of CA 19-9 Blood Level Before and After the Treatment of Pancreatic Ductal Adenocarcinoma: Analysis of 1,446 Patients from the Pancreatic Cancer Cohort in a Single
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA. - Abstract - Europe PMC
![PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a96fc01f495907ea18214fdc7db7ffd9b210d72c/2-TableI-1.png "PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar")
PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma | PLOS ONE
What Is CA 19-9 Tumor Marker Blood Test and its Normal Range I Pancreatic Cancer - YouTube
CA19-9 - Wikipedia
Ovarian tumor markers: What to draw and when | MDedge ObGyn
Clinical Significance of Tumour Markers | Semantic Scholar
Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports
Tumor Markers:- Part 7 - CA 125 and CA 19-9 - Labpedia.net
Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer—a report of two cases - Al-Shamsi - Journal of Gastrointestinal
